Bullard Receives NIOSH Approval for Combination Filter for Powered-Air Purifying Respirator
EVA (Evolutionary Air), the newest Powered Air-Purifying Respirator (PAPR) from Bullard, is now approved by the National Institute for Occupational Safety and Health (NIOSH) with a combination chemical and particulate filter that protects users against organic vapors, chloride dioxide, chlorine, hydrogen chloride, hydrogen fluoride, sulfur dioxide and particulates at a high efficiency level.
EVA (Evolutionary Air), the newest Powered Air-Purifying Respirator (PAPR) from Bullard, is now approved by the National Institute for Occupational Safety and Health (NIOSH) with a combination chemical and particulate filter that protects users against organic vapors, chloride dioxide, chlorine, hydrogen chloride, hydrogen fluoride, sulfur dioxide and particulates at a high efficiency level.
Bullard designed EVA from input received from users and experts in the field and the result is a technologically-advanced PAPR that offers constant air flow in a compact, ergonomic, lightweight design. Offering 1,000 Assigned Protection Factor, EVA is equipped with an innovative Active Flow Technology system that automatically maintains constant air flow and an easy-to-read fuel gauge that lets the user quickly check the units battery status.
Additional EVA features include:
-- Two distinct audible alarms that notify wearers of low battery and low air flow. The sound from the alarms travels through the breathing tube directly to the users ear.
-- A long-lasting 10,000-hour brushless motor that is designed for long-term reliable use.
-- Two-speed blower so the user can choose more or less cooling and air flow.
-- Filter locking tab that notifies the user that the filter is in place with both a visual indication and audible click.
-- Contoured belt made of closed-cell, chemically-resistant foam shaped to contour to the wearers back for extra comfort.
EVA is NIOSH approved with Bullard Tychem® Hoods and Loose-Fitting Hoods, Spectrum® Series Full Facepiece, and the FAMB Series Half-Mask.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
